AxoGen Inc reports results for the quarter ended in March - Earnings Summary

AxoGen

09/05/2023 14:34

* AxoGen Inc  AXGN.OQ  reported a quarterly adjusted loss
of 10
cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 14 cents per share.
    * Revenue rose 18.2% to $36.66 million from a year ago;
analysts
expected $35.37 million. 
    * AxoGen Inc's reported EPS for the quarter was a loss of 17
cents​.
    * The mean earnings estimate of analysts had risen by
about 19.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AxoGen Inc shares had risen by 2.2% this quarter and
lost 3.2%
so far this year.
    * The company reported a quarterly loss of $7.07 million.
    * Wall Street's median 12-month price target for AxoGen Inc
is
$17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 01:33 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.14          -0.10          Beat
 Dec. 31 2022      -0.11          -0.03          Beat
 Sep. 30 2022      -0.12          -0.01          Beat
 Jun. 30 2022      -0.14          -0.06          Beat